Daniel E. Owens - 02 Dec 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
Chief Human Resources Officer
Signature
Lisa Taylor as Attorney-in-fact for Dan Owens
Issuer symbol
TMCI
Transactions as of
02 Dec 2022
Net transactions value
-$82,395
Form type
4
Filing time
02 Dec 2022, 20:00:15 UTC
Previous filing
17 Nov 2022
Next filing
10 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Options Exercise $26,355 +3,750 +35% $7.03 14,450 02 Dec 2022 Direct F1, F2
transaction TMCI Common Stock Sale $93,750 -3,750 -26% $25.00 10,700 02 Dec 2022 Direct F1, F2
transaction TMCI Common Stock Options Exercise $31,875 +1,875 +18% $17.00 12,575 02 Dec 2022 Direct F1, F2
transaction TMCI Common Stock Sale $46,875 -1,875 -15% $25.00 10,700 02 Dec 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option Right to Buy Options Exercise $0 -3,750 -2% $0.000000 182,625 02 Dec 2022 Common Stock 3,750 $7.03 Direct F3
transaction TMCI Stock Option Right to Buy Options Exercise $0 -1,875 -2.5% $0.000000 71,688 02 Dec 2022 Common stock 1,875 $17.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option exercise and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 Includes 6,700 RSUs.
F3 The stock option vests in equal annual installments over 4 years, commencing on February 2, 2022, with the last installment on February 2, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.
F4 The stock option vests in equal annual installments over 4 years, commencing on April 22, 2022, with the last installment on April 22, 2025, subject to Reporting Person's providing continued service to Issuer through each vesting date.